DE NOVO CANCER INCIDENCE IN ELDERLY LIVER TRANSPLANT RECIPIENTS RECEIVING INDUCTION IMMUNOSUPPRESSION

被引：0
|
作者：
Dalbec, Kathryn M. [1 ]
Mangus, Richard S. [1 ]
Fridell, Jonathan A. [1 ]
Vianna, Rodrigo M. [1 ]
Tector, A. Joseph [1 ]
机构：
[1] Indiana Univ, Sch Med, Dept Surg, Transplant Div, Indianapolis, IN 46202 USA
来源：
LIVER TRANSPLANTATION | 2008年 / 14卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S130 / S130
页数：1
相关论文
共 50 条
  • [41] Post Liver Transplant Cancer Risk in Patients Receiving Antibody-Based Immunosuppression Induction
    Mangus, R.
    Graham, R.
    Maluccio, M.
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 : S164 - S164
  • [42] Incidence of De Novo Donor Specific Antibodies in Kidney Transplant Recipients
    Staino, C.
    Pilch, N.
    Moussa, O.
    Boyle, K.
    Casale, J.
    Covert, K.
    Fleming, J.
    Taber, D.
    Meadows, H.
    Mardis, C.
    Chavin, K.
    Nadig, S.
    McGillicuddy, J.
    Bratton, C.
    Srinivas, T.
    Baliga, P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [43] Incidence, risk factors and outcome of de novo tumors in liver transplant recipients focusing on alcoholic cirrhosis
    Jimenez-Romero, Carlos
    Justo-Alonso, Iago
    Cambra-Molero, Felix
    Calvo-Pulido, Jorge
    Garcia-Sesma, Alvaro
    Abradelo-Usera, Manuel
    Caso-Maestro, Oscar
    Manrique-Municio, Alejandro
    WORLD JOURNAL OF HEPATOLOGY, 2015, 7 (07) : 942 - 953
  • [44] Incidence, risk factors and outcome of de novo tumors in liver transplant recipients focusing on alcoholic cirrhosis
    Carlos Jiménez-Romero
    Iago Justo-Alonso
    Félix Cambra-Molero
    Jorge Calvo-Pulido
    álvaro García-Sesma
    Manuel Abradelo-Usera
    Oscar Caso-Maestro
    Alejandro Manrique-Municio
    World Journal of Hepatology, 2015, (07) : 942 - 953
  • [45] Poor Outcomes in Elderly Kidney Transplant Recipients Receiving Alemtuzumab Induction
    Hurst, Frank P.
    Altieri, Maria
    Nee, Robert
    Agodoa, Lawrence Y.
    Abbott, Kevin C.
    Jindal, Rahul M.
    AMERICAN JOURNAL OF NEPHROLOGY, 2011, 34 (06) : 534 - 541
  • [46] Improving immunosuppression in de novo kidney recipients
    Schlegel, A.
    Tschuor, C.
    Oberkofler, C.
    Schiesser, M.
    Fehr, T.
    Dutkowski, P.
    Clavien, P. -A.
    Brockmann, J.
    BRITISH JOURNAL OF SURGERY, 2012, 99 : 16 - 17
  • [47] Everolimus Immunosuppression in De Novo Heart Transplant Recipients: Clinical and Intravascular Ultrasound Study
    Choi, H.
    Hong, J.
    Kim, M.
    Lee, S.
    Kim, J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2019, 38 (04): : S280 - S280
  • [48] Psychiatric Morbidity in De Novo Heart Transplant Recipients on Everolimus-Based Immunosuppression
    Buerker, B. S.
    Malt, U. F.
    Gude, E.
    Gullestad, L.
    Relbo, A.
    Grov, I.
    Andreassen, A. K.
    Fiane, A. E.
    Haraldsen, I. R.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2016, 35 (04): : S288 - S289
  • [49] Post-transplant de novo malignancies in pediatric renal transplant recipients: Conversion to sirolimus immunosuppression
    Garcia, C.
    Bittencourt, V.
    Malheiros, D.
    Tumelero, A.
    Antonello, J.
    Oliveira, A.
    Garcia, V.
    PEDIATRIC NEPHROLOGY, 2007, 22 (09) : 1478 - 1478
  • [50] Weaning of immunosuppression in liver transplant recipients
    Mazariegos, GV
    Reyes, J
    Marino, IR
    Demetris, AJ
    Flynn, B
    Irish, W
    McMichael, J
    Fung, JJ
    Starzl, TE
    TRANSPLANTATION, 1997, 63 (02) : 243 - 249
12345